ABVC BioPharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards, Foreign
ABVC BioPharma, Inc. (ABVC) had Deferred Tax Assets, Operating Loss Carryforwards, Foreign of $5.87 million as of 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign · last filed 2025-04-30
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $5.87M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $5.68M.
- 2024-09-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $5.63M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards, Foreign $5.61M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign as first filed |
|---|---|---|
| 2025-03-31 | $5.87M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $5.68M 10-Q · filed 2025-04-30 | |
| 2024-09-30 | $5.63M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $5.61M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $5.61M 10-Q · filed 2024-05-17 | |
| 2023-12-31 | $5.02M 10-K · filed 2025-04-15 | $5.57M 10-K · filed 2024-03-13 |
| 2023-09-30 | $5.71M 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $5.68M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $6.98M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.87M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $402.25K 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $2.80M 10-K · filed 2023-03-31 | $283.73K 10-Q · filed 2022-11-14 |